NDC 0074-0501 – Vyalev

Foscarbidopa 12 mg/mL; Foslevodopa 240 mg/mL · Injection · Subcutaneous

Human Prescription Drug

Product NDC0074-0501

Product details

Brand name
Vyalev
Generic name
Foscarbidopa/foslevodopa
Labeler
AbbVie Inc.
Dosage form
Injection
Route
Subcutaneous
Marketing category
NDA · NDA216962
Marketed since
April 12, 2022
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Vyalev →

Package NDC codes (1)

Package NDCDescriptionSince
0074-0501-017 VIAL, SINGLE-DOSE in 1 CARTON (0074-0501-01) / 10 mL in 1 VIAL, SINGLE-DOSEApr 12, 2022